ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $541,741 | -2.0% | 27,709 | 0.0% | 0.11% | -9.0% |
| Q2 2023 | $553,072 | +2.0% | 27,709 | 0.0% | 0.12% | -40.5% |
| Q4 2022 | $542,265 | +26.1% | 27,709 | 0.0% | 0.20% | +95.2% |
| Q3 2022 | $430,000 | +7.5% | 27,709 | 0.0% | 0.10% | +19.3% |
| Q2 2022 | $400,000 | -8.9% | 27,709 | 0.0% | 0.09% | +2.3% |
| Q1 2022 | $439,000 | -32.0% | 27,709 | 0.0% | 0.09% | -23.2% |
| Q4 2021 | $646,000 | -21.6% | 27,709 | 0.0% | 0.11% | -25.3% |
| Q3 2021 | $824,000 | -34.3% | 27,709 | 0.0% | 0.15% | -38.5% |
| Q2 2021 | $1,255,000 | +7.9% | 27,709 | 0.0% | 0.24% | -0.8% |
| Q1 2021 | $1,163,000 | -24.4% | 27,709 | 0.0% | 0.25% | -29.7% |
| Q4 2020 | $1,538,000 | +99.2% | 27,709 | 0.0% | 0.35% | +66.7% |
| Q3 2020 | $772,000 | – | 27,709 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |